Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 1,182 | 2,007 | 1,721 | 1,971 | 2,617 |
| Operating Income | -1,170 | -2,007 | -1,721 | -1,971 | -2,617 |
| Other Income | -4 | 0 | 4 | 18 | 10 |
| Pre-tax Income | -1,174 | -2,007 | -1,717 | -1,952 | -2,607 |
| Net Income Continuous | -1,186 | -2,007 | -1,717 | -1,952 | -2,702 |
| Net Income | $-1,186 | $-2,007 | $-1,717 | $-1,952 | $-2,702 |
| EPS Basic Total Ops | -86.41 | -158.42 | -136.81 | -154.82 | -270.03 |
| EPS Basic Continuous Ops | -87.74 | -158.87 | -136.17 | -155.33 | -270.34 |
| EPS Diluted Total Ops | -86.41 | -158.42 | -136.81 | -154.82 | -230.42 |
| EPS Diluted Continuous Ops | -87.74 | -158.87 | -136.17 | -155.33 | -232.57 |
| EBITDA(a) | $-1,173 | $-1,999 | $-1,713 | $-1,964 | $-2,604 |